Analysis

Surenano Science Ltd (SURE) Stock Analysis

Surenano Science Ltd investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to SURE.

websiteSURE/analysis/SURE

Surenano Science Ltd

Surenano Science Ltd investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to SURE.

Stock profile

Ticker

SURE

Asset type

Stock

Market cap

$3.6M

Sector

Health Technology

Industry

Pharmaceuticals: Other

Currency

CAD

Ticker listings

Surenano Science Ltd may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • SURE primary listing
  • SURNF

Latest Surenano Science Ltd news

SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies for GLP GEP-44 and Enters Discussions to Acquire Ibogaine Fo...

GLP-compliant program covering rodents, non-rodents, and primates will define safety, MTD and safe dose ranges, targeting weight loss and TIIDMNovel Ibogaine formulation develop...

SureNano Science Ltd. Acquires GlucaPharm Inc., Advancing Second-Generation FDA Pathway GLP-1 Drug Development

GlucaPharm is developing GEP44, a novel, patented peptide (similar in function to Ozempic®, Wegovy®, Mounjaro®, but with reduced risk of adverse events) discovered by researcher...

SureNano Announces Stock Option Grant

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) (the "Company" or "SureNano") announces that it has granted ...

SureNano Announces Closing of $1,250,000 Private Placement

Vancouver, British Columbia--(Newsfile Corp. - December 10, 2025) - SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) (the "Company" or "SureNano") is pleased to announce, as a f...

SureNano Announces Non-Binding Letter of Intent to Negotiate Proposed Transaction of GlucaPharm Inc. for GLP-1 Drug Development

Vancouver, British Columbia--(Newsfile Corp. - November 19, 2025) - SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) (the "Company" or "SureNano") is pleased to announce it has ...

Research sections

Valuation

Review valuation context for Surenano Science Ltd.

Future growth

Review future growth context for Surenano Science Ltd.

Past performance

Review past performance context for Surenano Science Ltd.

Financial health

Review financial health context for Surenano Science Ltd.

Dividend

Review dividend context for Surenano Science Ltd.

Management

Review management context for Surenano Science Ltd.

Ownership

Review ownership context for Surenano Science Ltd.

Other information

Review other information context for Surenano Science Ltd.

Community

Review community context for Surenano Science Ltd.